As the Sr Director of Business Development for the Modeling Lab at Tempus Labs, I leverage my education and over 15 years of sales experience to identify and cultivate new opportunities for in vitro patient-derived organoid drug screening in the biopharmaceutical sector. I am passionate about enabling impactful and personalized cancer therapies by combining multiomics and real world data with cutting-edge organoid technology.I also oversee the market expansion of tumor microenvironment analyses using patient-derived explants and single cell and spatial workflows, developing and implementing commercial strategies that meet the needs and expectations of our customers. I have a proven track record of launching and scaling game-changing products, such as the Xenium in situ product at 10x Genomics, where I directly contributed to the placement of over 200 instruments in the first year. I enjoy distilling complex concepts into accessible and actionable information, and empowering scientific investigators to advance their research with innovative solutions.My views are my own.